A Smart + Strong Site
Subscribe to:
Newsletters
POZ magazine
JOIN AIDSMEDS YouTube

Back to home » Treatment News » Top Stories


May 29, 2009
Is Marijuana as Effective as OTC and Prescription Drugs?
People who use marijuana to treat symptoms of anxiety, fatigue and neuropathy say it is as effective as over-the-counter (OTC) remedies or prescription drugs recommended by their health care providers, according to a survey-based study published in the May 2009 issue of Clinical Nursing Research.
May 28, 2009
Viral Load Tied to Kidney Function
As viral load increases so does the risk of kidney problems, according to a study published in the June 1 issue of AIDS and reported by aidsmap. Fortunately, with decreases in viral load and increases in CD4 cells resulting from antiretroviral (ARV) treatment, kidney function is likely to improve.  
May 27, 2009
New California Budget Slashes $55.5 Million From AIDS Funds
On May 26, California Governor Arnold Schwarzenegger released his plan to cut $5.5 billion through June 2010 from the state budget to help close its budget gap, which currently stands at $24.3 billion, the San Francisco Chronicle reports. The budget includes cuts to California’s AIDS drug assistance program (ADAP) and other programs overseen by the state Office of AIDS.
Kaletra Maintenance Monotherapy Holds Up Over 96 Weeks
People who switched to Kaletra (lopinavir plus ritonavir) monotherapy after six months of combination antiretroviral (ARV) therapy were as likely as people who stayed on a three-drug regimen to have treatment success, according to a study published in the June issue of the Journal of Acquired Immune Deficiency Syndromes.
May 26, 2009
Combivir Linked to Lipoatrophy in Small European Study
Combivir is a likely contributor to limb fat loss and possibly abdominal fat gain in people living with HIV, according to a European study published May 21 in the online scientific journal PLoS One.
May 22, 2009
Gingko May Lower Efavirenz Blood Levels
Combining the herbal therapy gingko biloba with efavirenz (found in Sustiva and Atripla) could result in efavirenz treatment failure, according to a single case report published in the June 1 issue of AIDS and reported by aidsmap.
May 21, 2009
Frequent False-Positive Drug Tests With Efavirenz Users
Ninety-eight percent of people with HIV on a regimen containing efavirenz (found in Sustiva and Atripla) tested false positive for benzodiazepines—prescription sedatives—on a widely used drug test, according to study results published online in Clinical Infectious Diseases. These data suggest that clinicians and others who order routine testing for illicit drug use need to use extra caution when interpreting the results involving people using efavirenz.
May 20, 2009
Is HIV Itself a Risk Factor for Heart Disease?
Even HIV-positive patients with undetectable viral loads and not on antiretroviral (ARV) therapy have thicker carotid arteries than HIV-negative patients, according to a study published in the June 1 issue of AIDS. While these data confirm that people living with HIV may be at a higher risk for cardiovascular disease (CVD) as they age, the findings also raise important questions about the underlying cause of the increased CVD risk among HIV-positive people. 
May 19, 2009
HIV Associated With Marked Declines in Lung Function
Middle-aged people living with HIV experience declines in pulmonary function comparable to those typically seen in elderly HIV-negative individuals with a long history of smoking, according to a new study reported Sunday, May 17, at the 105th International Conference of the American Thoracic Society (ATS) in San Diego.
Study Authors Say Treat HIV and OIs at Same Time
Beginning HIV treatment right away in people who are diagnosed with HIV only after coming down with an opportunistic infection (OI)—rather than waiting until the OI treatment takes effect—may reduce early disease progression or deaths without increasing treatment complications, according to a study published in the online journal PLoS One and reported by ScienceDaily.
May 15, 2009
Interleukin-21 Tied to Control of Chronic Infections Like HIV
An immune signaling protein called interleukin-21 (IL-21) plays a critical role in the long-term control of chronic viral infections such as HIV disease, according to a study published online in Science and reported by ScienceDaily.
May 14, 2009
Study: HIV Not Becoming More Virulent
HIV is not becoming more virulent over time, according to a French study published online May 6 in AIDS and reported by aidsmap. These results contrast with those of a U.S. study first reported at a conference in October 2008 and published earlier this month in The Journal of Infectious Diseases
May 13, 2009
Gardasil Blocks About Half of Cervical Lesions
The human papilloma virus (HPV) vaccine Gardasil reduced the number of abnormal cervical Pap test results by 17 to 45 percent, depending on the abnormality, according to a study presented at the International Papillomavirus Conference in Malmö, Sweden. The vaccine also reduced the need for invasive diagnostic and treatment produces in women ages 16 to 26 compared with those who received a placebo. 
May 12, 2009
HPV Vaccine Is Active in MSM
The vaccine Gardasil provides at least short-term protection in men who have sex with men (MSM) against human papillomavirus (HPV) strains known to cause cancer, according to a study presented at the International Papillomavirus Conference in Malmö, Sweden.
May 11, 2009
Journalist Files Libel Suit Against HIV Treatment Advocate
Journalist Celia Farber has filed a 21-page libel suit against Richard Jefferys of the HIV/AIDS research- and policy-focused Treatment Action Group, accusing him of orchestrating a smear campaign against her, the New York Post reports. 
May 08, 2009
Telaprevir Increases Hep C Treatment Response
Adding the experimental hepatitis C virus (HCV) protease inhibitor telaprevir to standard HCV therapy both increased the response rate and shortened the duration of treatment in HIV-negative patients infected with HCV genotype 1, according to a study published April 30 in The New England Journal of Medicine.
May 07, 2009
Hep C and Heavy Drinking Tied to Bone Fractures
Neither CD4 count and viral load, nor type of antiretroviral (ARV) treatment was associated with a higher risk for having a severe bone fracture in people living with HIV, but being coinfected with hepatitis C virus (HCV) and drinking five or more drinks per day were, according to a French study published in the May 15 issue of AIDS and reported by aidsmap.
May 06, 2009
Obama to Broaden, Expand PEPFAR to $51 Billion Over Six Years
President Barack Obama wants to expand former President George W. Bush’s President’s Emergency Plan for AIDS Relief (PEPFAR); on Tuesday, he asked Congress to spend $51 billion over the next six years to fight AIDS, tuberculosis and malaria overseas while allocating an additional $12 billion toward other global health concerns, The New York Times reports.
May 05, 2009
Lower-Dose ARVs to Be Tested in New Gates-Funded Program
Can using lower doses of certain antiretrovirals deliver a high degree of effectiveness while reducing the risk of side effects and the cost associated with HIV treatment? A series of studies, funded with a $12.4 million grant from the Bill & Melinda Gates Foundation, is determined to find out.
May 04, 2009
HPV Greatly Increases HIV Infection in MSM
Men who have sex with men (MSM) and who are also infected with the human papillomavirus (HPV) have a much higher risk of becoming infected with HIV than men who do not have HPV infection, according to a study published online April 22 in AIDS and reported by Medical News Today. If an HPV vaccine currently being studied in MSM protects against HPV infection, however, it might help prevent transmission of HIV as well.
May 01, 2009
Turning On Old Genes to Prevent HIV
Researchers may be better poised to develop a cream or gel that might help prevent transmission of HIV, thanks to the results of a study published April 28 in PloS Biology. The cream would work by reawakening an inactive virus-fighting human gene.
Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
 
Archive

December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
October 2005

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter


Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014


21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014


7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.